Your browser doesn't support javascript.
loading
Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age.
Zhao, Peng; Hou, Ming; Liu, Yi; Liu, Hui-Xin; Huang, Rui-Bin; Yao, Hong-Xia; Niu, Ting; Peng, Jun; Jiang, Ming; Han, Yan-Qiu; Hu, Jian-Da; Zhou, Hu; Zhou, Ze-Ping; Qiu, Lin; Zhang, Lian-Sheng; Wang, Xin; Wang, Hua-Quan; Feng, Ru; Yang, Lin-Hua; Ma, Liang-Ming; Wang, Shun-Qing; Kong, Pei-Yan; Wang, Wen-Sheng; Sun, Hui-Ping; Sun, Jing; Zhou, He-Bing; Zhu, Tie-Nan; Wang, Li-Ru; Zhang, Jing-Yu; Huang, Qiu-Sha; Liu, Xiao; Fu, Hai-Xia; Li, Yue-Ying; Wang, Qian-Fei; Jiang, Qian; Jiang, Hao; Lu, Jin; Zhang, Xiao-Hui.
Afiliação
  • Zhao P; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
  • Hou M; National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Liu Y; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Liu HX; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
  • Huang RB; Department of Hematology, Qilu Hospital, Shandong University, Jinan, China.
  • Yao HX; Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, China.
  • Niu T; Department of Clinical Epidemiology, Peking University People's Hospital, Beijing, China.
  • Peng J; Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Jiang M; Department of Hematology, Hainan General Hospital, Haikou, China.
  • Han YQ; Department of Hemotology, West China Hospital, Sichuan University, Chengdu, China.
  • Hu JD; Department of Hematology, Qilu Hospital, Shandong University, Jinan, China.
  • Zhou H; Department of Hematology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
  • Zhou ZP; Department of Hematology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
  • Qiu L; Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China.
  • Zhang LS; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Wang X; Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Wang HQ; Department of Hematology, The First Hospital of Jilin University, Changchun, China.
  • Feng R; Department of Hematology, Lanzhou University Second Hospital, Lanzhou, China.
  • Yang LH; Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
  • Ma LM; Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China.
  • Wang SQ; Department of Hematology, Beijing Hospital, Ministry of Health, Beijing, China.
  • Kong PY; Department of Hematology, Second Affiliated Hospital of Shanxi Medical University, Taiyuan, China.
  • Wang WS; Department of Hematology, Affiliated Shanxi Big Hospital of Shanxi Medical University, Taiyuan, China.
  • Sun HP; Department of Hematology, Guangzhou First People's Hospital, Guangzhou, China.
  • Sun J; Xinqiao Hospital, The Third Military Medical University, Chongqing, China.
  • Zhou HB; Department of Hematology, Peking University First Hospital, Beijing, China.
  • Zhu TN; Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang LR; Nanfang Hospital, Nanfang Medical University, Guangzhou, China.
  • Zhang JY; Beijing Luhe Hospital, Capital Medical University, Beijing, China.
  • Huang QS; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Liu X; Fuxing Hospital, Capital Medical University, Beijing, China.
  • Fu HX; Department of Hematology, Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Li YY; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
  • Wang QF; National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Jiang Q; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Jiang H; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
  • Lu J; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
  • Zhang XH; National Clinical Research Center for Hematologic Disease, Beijing, China.
Platelets ; 32(5): 633-641, 2021 Jul 04.
Article em En | MEDLINE | ID: mdl-32614630
Intracranial hemorrhage (ICH) is a devastating complication of immune thrombocytopenia (ITP). However, information on ICH in ITP patients under the age of 60 years is limited, and no predictive tools are available in clinical practice. A total of 93 adult patients with ITP who developed ICH before 60 years of age were retrospectively identified from 2005 to 2019 by 27 centers in China. For each case, 2 controls matched by the time of ITP diagnosis and the duration of ITP were provided by the same center. Multivariate analysis identified head trauma (OR = 3.216, 95%CI 1.296-7.979, P =.012), a platelet count ≤ 15,000/µL at the time of ITP diagnosis (OR = 1.679, 95%CI 1.044-2.698, P =.032) and severe/life-threatening bleeding (severe bleeding vs. mild bleeding, OR = 1.910, 95%CI 1.088-3.353, P =.024; life-threatening bleeding vs. mild bleeding, OR = 2.620, 95%CI 1.360-5.051, P =.004) as independent risk factors for ICH. Intraparenchymal hemorrhage (OR = 5.191, 95%CI 1.717-15.692, P =.004) and a history of severe bleeding (OR = 4.322, 95%CI 1.532-12.198, P =.006) were associated with the 30-day outcome of ICH. These findings may facilitate ICH risk stratification and outcome prediction in patients with ITP.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Púrpura Trombocitopênica Idiopática / Hemorragias Intracranianas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Púrpura Trombocitopênica Idiopática / Hemorragias Intracranianas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article